NCT04153591View on ClinicalTrials.gov

Efficacy and Safety of Direct Oral Anticoagulants for the Treatment of Mural Thrombus

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

November 5, 2019

Primary Completion Date

June 22, 2020

Study Completion Date

June 22, 2020

Conditions
Acute Myocardial Infarction
Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER

NCT04153591 - Efficacy and Safety of Direct Oral Anticoagulants for the Treatment of Mural Thrombus | Biotech Hunter | Biotech Hunter